It is a chemicals public limited company based in U.T. Chandigarh., Chandigarh, India, established in 2006.
2006 | U.T. Chandigarh., Chandigarh, India | ActiveRaycure Drugs Limited, a active public limited company, was established on 02 January 2006 in U.T. Chandigarh., Chandigarh, India. Engaging in chemical products within the manufacturing sector, it holds CIN: U00304CH2006PLC029458. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Tarsem Kumar Ruby (Director), Veeta Sharma (Director), Sanjay Jhamb (Additional Director). Past directors included Sat Parkash Mittal. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sco 859, Nac Manimajra,U.T. Chandigarh., U.T. Chandigarh., Chandigarh.
U00304CH2006PLC029458
029458
02 January 2006
₹0.50 M
₹0.50 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Raycure Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarsem Kumar Ruby | Director | 02 Jan 2006 | Current |
| Veeta Sharma | Director | 02 Jan 2006 | Current |
| Sanjay Jhamb | Additional Director | 31 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Aug 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Raycure Drugs Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 16.88% decrease. The company also saw a substantial improvement in profitability, with a 42.58% increase in profit. The company's net worth observed a substantial decline by a decrease of 356.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Raycure Drugs had a promoter holding of 92.00% and a public holding of 8.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Raycure Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Raycure Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raycure Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Raycure Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Raycure Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
Sanjay Jhamb was appointed as a Additional Director was appointed as a Additional Director on 31 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
The activity Tarsem Kumar Ruby was appointed as a Director was appointed as a Director on 02 Jan 2006 & has been associated with this company since 19 years 10 months . was completed.
Progress on Veeta Sharma was appointed as a Director was appointed as a Director on 02 Jan 2006 & has been associated with this company since 19 years 10 months . was documented.
Progress on Raycure Drugs Limited was registered on 02 Jan 2006 with Roc Chandigarh & aged 19 years 10 months as per MCA records. was documented.
The CIN of Raycure Drugs Limited is U00304CH2006PLC029458.
Raycure Drugs Limited is headquartered at Sco 859, Nac Manimajra,U.T. Chandigarh., U.T. Chandigarh., Chandigarh.
Raycure Drugs Limited was incorporated on 02 January 2006.
The current directors of Raycure Drugs Limited are
The primary industry of Raycure Drugs Limited is Manufacturing.
Raycure Drugs Limited is unlisted.
The authorized capital of Raycure Drugs Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Raycure Drugs Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX